Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 8.25% is 170% above its 5-year average of 3.06%, near the high end of its 5-year range (-6.76%–8.25%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.84% above its 12-month average of 7.73%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 8.25%.
RETURN ON EQUITY (ROE)
8.25%
RETURN ON EQUITY (ROE) AVG TTM
7.73%
RETURN ON EQUITY (ROE) AVG 3Y
5.82%
RETURN ON EQUITY (ROE) AVG 5Y
3.06%
RETURN ON EQUITY (ROE) AVG 10Y
5.55%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+6.84%
CURRENT VS 3Y AVG
+41.73%
CURRENT VS 5Y AVG
+169.57%
CURRENT VS 10Y AVG
+48.87%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 745 covered companies
CURRENT VS SECTOR MEDIAN
+119.65%
vs the sector median at left
Kamada Ltd.
Market Cap
$471.07M
Return on Equity (ROE)
8.25%
TTM Avg
7.73%
3Y Avg
5.82%
5Y Avg
3.06%
Market Cap
$472.52M
Return on Equity (ROE)
-24.02%
TTM Avg
-22.16%
3Y Avg
-34.88%
5Y Avg
-37.32%
Market Cap
$476.63M
Return on Equity (ROE)
-26.79%
TTM Avg
-28.77%
3Y Avg
-36.48%
5Y Avg
-24.33%
Market Cap
$474.59M
Return on Equity (ROE)
-9.69%
TTM Avg
-30.79%
3Y Avg
-49.02%
5Y Avg
-53.00%
Market Cap
$468.00M
Return on Equity (ROE)
-56.26%
TTM Avg
-59.48%
3Y Avg
-54.76%
5Y Avg
-34.52%
Market Cap
$475.20M
Return on Equity (ROE)
1.65%
TTM Avg
-27.02%
3Y Avg
-39.92%
5Y Avg
-33.78%
Market Cap
$476.10M
Return on Equity (ROE)
-8.21%
TTM Avg
-32.76%
3Y Avg
-79.80%
5Y Avg
-71.61%
Market Cap
$486.60M
Return on Equity (ROE)
19.28%
TTM Avg
28.37%
3Y Avg
24.29%
5Y Avg
382.68%
Market Cap
$486.78M
Return on Equity (ROE)
N/A
TTM Avg
-344.79%
3Y Avg
-198.42%
5Y Avg
-104.57%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kamada Ltd. (KMDA) | $471.07M | 8.25% | 7.73% | 5.82% | 3.06% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $472.52M | -24.02% | -22.16% | -34.88% | -37.32% |
| Alpha Teknova, Inc. (TKNO)vs › | $476.63M | -26.79% | -28.77% | -36.48% | -24.33% |
| Cerus Corporation (CERS)vs › | $474.59M | -9.69% | -30.79% | -49.02% | -53.00% |
| Sight Sciences, Inc. (SGHT)vs › | $468.00M | -56.26% | -59.48% | -54.76% | -34.52% |
| Arvinas, Inc. (ARVN)vs › | $475.20M | 1.65% | -27.02% | -39.92% | -33.78% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $476.10M | -8.21% | -32.76% | -79.80% | -71.61% |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.60M | 19.28% | 28.37% | 24.29% | 382.68% |
| Evolus, Inc. (EOLS)vs › | $486.78M | N/A | -344.79% | -198.42% | -104.57% |
| NRC Health (NRC)vs › | $455.24M | 89.43% | 81.07% | 67.39% | 61.90% |
ROE
8.3%
ROA
5.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 8.25% |
| 2026-03-31 | 7.85% |
| 2025-12-31 | 7.51% |
| 2025-09-30 | 7.71% |
| 2025-06-30 | 7.31% |
| 2025-03-31 | 6.37% |
| 2024-12-31 | 5.57% |
| 2024-09-30 | 6.16% |
| 2024-06-30 | 6.00% |
| 2024-03-31 | 5.05% |
| 2023-12-31 | 3.39% |
| 2023-09-30 | 2.59% |
| 2023-06-30 | 1.94% |
| 2023-03-31 | -1.32% |
| 2022-12-31 | -1.32% |
| 2022-09-30 | -5.95% |
| 2022-06-30 | -6.76% |
| 2022-03-31 | -3.85% |
| 2021-12-31 | -1.26% |
| 2021-09-30 | 2.43% |
| 2021-06-30 | 6.63% |
| 2021-03-31 | 8.06% |
| 2020-12-31 | 9.59% |
| 2020-09-30 | 11.81% |
| 2020-06-30 | 11.70% |
| 2020-03-31 | 13.60% |
| 2019-12-31 | 16.44% |
| 2019-09-30 | 26.61% |
| 2019-06-30 | 21.31% |
| 2019-03-31 | 22.10% |
| 2018-12-31 | 19.84% |
| 2018-09-30 | 11.50% |
| 2018-06-30 | 13.51% |
| 2018-03-31 | 13.47% |
| 2017-12-31 | 7.71% |
| 2017-09-30 | -1.38% |
| 2017-06-30 | -2.87% |
| 2017-03-31 | -13.31% |
| 2016-12-31 | -10.09% |
| 2016-09-30 | -5.73% |
| 2016-06-30 | -10.83% |
| 2016-03-31 | -11.68% |
| 2015-12-31 | -15.54% |
| 2015-09-30 | -14.78% |
| 2015-06-30 | -11.68% |
| 2015-03-31 | -19.53% |
| 2014-12-31 | -15.60% |
| 2014-09-30 | -16.32% |
| 2014-06-30 | -12.27% |
| 2014-03-31 | -0.73% |
| 2013-12-31 | 0.49% |
| 2013-09-30 | 2.14% |
| 2013-06-30 | 2.24% |
| 2013-03-31 | -4.88% |
